◇日 時 ：2025年3月11日（火）10時～17時
3月12日（水）10時～15時
◇会 場 ：bcゲーム 入金ボーナス 愛学館2階・A21講義室
2025年3月11日（火）・12日（水）にbcゲーム 入金ボーナス（京都市山科区、学長：赤路健一）において2024年度国際シンポジウム(KPU InternationalSymposium)を「次世代のがんプロフェッショナル養成プラン」（文部科学省）との共催で開催します。
本シンポジウムは本学独自の研究推進事業「シナジーbcゲーム 入金ボーナス研究」や「国際bcゲーム 入金ボーナス研究」で2023年度に採択された事業、
- 神経変性疾患の早期診断・疾患修飾・機能補填を包括するニューロセラノスティクスの開発
- 膜タンパク質と脂質の協奏機構解明に向けた分子化学的研究と新規膜受容体機能調製因子の創製
- 脂肪由来幹細胞と免疫賦活剤を組み合わせた次世代治療法の開発
に関連して学内外の研究者と共同で行った研究成果について発表し、意見交換を行います。さらに本年度のプログラムは、上記研究分野における国内外の第一線で活躍する11名の卓越した研究者による先端的な講演を構成しています。bcゲーム 入金ボーナスの高度な研究基盤をもとに、革新的な学術的知見の交流と、次世代の共同研究への戦略的な展望を見据えた、極めて意義深い学術イベントとして企画しております。
また、本シンポジウムは本学の「次世代がんプロフェッショナル養成プラン」の共催で実施します。「次世代がんプロフェッショナル養成プラン」はがんbcゲーム 入金ボーナスの新たなニーズや急速ながんbcゲーム 入金ボーナスの高度化に対応できるbcゲーム 入金ボーナス人の育成を目指した取り組みを行っており、今後もこのような取り組みを通じて学際的な知識と技術の融合を推進、高度な専門性を持つ次世代のbcゲーム 入金ボーナス人育成を目指していきます。
2024年度bcゲーム 入金ボーナス実施概要
Date: March 11 (Tues) bcゲーム 入金ボーナス 12 (Wed), 2025
Venue: A21 Lecture Hall, Aigaku-kan Building, Kyoto Pharmaceutical University
program：KPU International SymposiumJoint with “Plan for Fostering Next-Generation Cancer Specialists” bcゲーム 入金ボーナス “KPU Synergetic Research Project Seminar”
March 11(Tue)-12(Wed)
Day1 (March 11)
Towards understbcゲーム 入金ボーナスing bcゲーム 入金ボーナス modulating biological phenomenon on the membrane
The disruption bcゲーム 入金ボーナス receptor tyrosine kinase (RTK)-mediated signaling is closely associated with severe diseases such as cancer. These receptors are known to function by interacting with a variety bcゲーム 入金ボーナス lipid molecules within biological membranes. This session will present the latest research uncovering the chemistry bcゲーム 入金ボーナス RTKs and their "concert" with lipid molecules. Insights from this session may lead to novel drug discovery strategies targeting RTKs.
10:00-10:30 Takeshi Sato (Kyoto Pharmaceutical University)
Suggestion from the computational chemistry for EGFR bcゲーム 入金ボーナス lipids
10:30-11:00 Hiroko Asahina (Kyoto Pharmaceutical University)
Strategy for structural analysis bcゲーム 入金ボーナス membrane protein with semi-synthesis
11:00-11:30 Francisco Barrera (University bcゲーム 入金ボーナス Tennessee, Knoxville)
Lipid control bcゲーム 入金ボーナス receptor tyrosine kinase assembly and function
11:30-12:00 Kazuya Kabayama (Osaka University)
Regulation bcゲーム 入金ボーナス dynamics bcゲーム 入金ボーナス plasma membrane-associated molecules by glycosylation
Synthesis and application bcゲーム 入金ボーナス molecular probe for membrane-related biological system
Dynamic molecular interactions such as lipid-lipid, lipid-protein, and protein-protein interaction in the cell membrane play crucial roles for a variety bcゲーム 入金ボーナス fundamental biological processes. Therefore, these interactions have attracted much attention as potential targets for drug discovery. This session will provide synthetic study bcゲーム 入金ボーナス artificial phospholipid for investigating lipid-protein interaction, and chemical biological approaches for immune response with the synthetic molecular probes. Furthermore, drug delivery system toward cancer cells based on carbohydrate-protein interactions will also be presented.
13:30-14:00 Takumi Furuta (Kyoto Pharmaceutical University)
Synthetic study bcゲーム 入金ボーナス catalytically active head group functionalized phospholipid
14:00-14:30 Yukari Fujimoto (Keio University）
Immunomodulatory functions bcゲーム 入金ボーナス cell membrane complex lipids: synthesis and selective activation
14:30-15:00 Xuefei Huang（Michigan State University, Department bcゲーム 入金ボーナス Chemistry)
New hyaluronan like polysaccharides with enhanced CD44 affinity for molecular imaging bcゲーム 入金ボーナス targeted drug delivery
Topics bcゲーム 入金ボーナス translational research in diagnosis and therapy bcゲーム 入金ボーナス various diseases using radioligands: From bench to bedside
Combination bcゲーム 入金ボーナス diagnosis and therapy using radiopharmaceuticals (radiolabeled ligands): radiotheranostics is attracting attention as a very useful approach for selecting the optimal treatment at the individual patient level (personalized medicine, precision medicine). In this session, we will provide cutting-edge research topics on the status bcゲーム 入金ボーナス target molecule discovery, ligand development, and clinical deployment to realize radiotheranostics. We hope that our lecture will be an opportunity for the audience to learn more about radiotheranostics and that it will become a basis for accelerating future transdisciplinary research.
15:30-16:00 Hidekazu Kawashima (Kyoto Pharmaceutical University)
Radiotheranostics bcゲーム 入金ボーナス highly malignant tumors: Our approach targeting cancer-associated fibroblasts (CAFs)
16:00-16:30 Koki Hasegawa (Fukushima Medical University)
Innovative nuclear medicine techniques bcゲーム 入金ボーナス radiopharmaceuticals: Bridging laboratory development bcゲーム 入金ボーナス clinical requirements
16:30-17:00 Michael Decker (University bcゲーム 入金ボーナス Würzburg)
Monitoring cardiac diseases by 18F-labebled GPCR ligands: Development bcゲーム 入金ボーナス PET-radiotracers based on sartans and CXCR2-ligands
Day２ (March 12)
Cross-disciplinary research aimed at developing Neurotheranostics for the diagnosis and treatment bcゲーム 入金ボーナス neurodegenerative diseases
As the global population ages, there is an urgent need to establish comprehensive measures for the early diagnosis and treatment bcゲーム 入金ボーナス neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, along with their management. The concept bcゲーム 入金ボーナス neurotheranostics is evolving; it is no longer just a tool for simultaneous diagnosis and treatment but is being redefined as a technological development that spans from basic research to actual clinical practice in the field bcゲーム 入金ボーナス neurodegenerative diseases. This symposium will bring together researchers from various fields, including genetic engineering, pharmacology, and medicine, to explore neurotheranostics. They will introduce and discuss approaches related to diagnosis, treatment, and regenerative medicine. It is anticipated that this collaborative effort across multiple academic disciplines will lead to synergistic research advancements in the development bcゲーム 入金ボーナス neurotheranostics.
10:00-10:20 Kazuyuki Takata (Kyoto Pharmaceutical University)
Application bcゲーム 入金ボーナス Neurotheranostics in Basic Research bcゲーム 入金ボーナス Alzheimer's Disease
10:20-10:40 Masatoshi Inden(Gifu Pharmaceutical University)
Developing bcゲーム 入金ボーナス Analyzing Cell Models for Protein Aggregation in Neurodegenerative Diseases.
10:40-11:20 Knut Woltjen (CiRA, Kyoto University)
Precision Genome Editing in Human Induced Pluripotent Stem Cells
11:20-11:00 Wado Akamatsu (Juntendo University)
iPS Cell-Based Disease Modeling bcゲーム 入金ボーナス Drug Discovery for Neurological Diseases.
Advancement bcゲーム 入金ボーナス cardiac disease therapy and application to new therapies using adipose-derived stem cells
Adipose-derived stem cells (ASCs) have emerged as a promising tool in regenerative medicine, particularly in the context bcゲーム 入金ボーナス cardiac disease therapy. This session will elucidate the mechanisms by which ASC-derived bioactive factors modulate cardiac function and facilitate myocardial repair, highlighting recent advances in cell-based therapeutic strategies. We will present findings from our collaborative research with National Taiwan University and introduce results from international clinical studies. By advancing international research collaborations, we aim to accelerate the development bcゲーム 入金ボーナス innovative and clinically translatable strategies for cardiac disease treatment.
13:30-14:00 Shinji Kobuchi (Kyoto Pharmaceutical University)
Therapeutic potential bcゲーム 入金ボーナス human adipose-derived stem cell-conditioned medium in cardiac disease
14:00-14:30 Wan-Tseng Hsu (National Taiwan University)
Exploring mitochondrial protective strategies in the context bcゲーム 入金ボーナス heart failure
14:30-15:00 Shin-Yi Lin (National Taiwan University)
Clinical utilization bcゲーム 入金ボーナス direct oral anticoagulant concentration monitoring
Be My Guest: bcゲーム 入金ボーナス Peak Episode2025.02.21 09:43
